anti-CD68 antibody [KP1] (FITC)
产品描述 | FITC-conjugated Mouse Monoclonal antibody [KP1] recognizes CD68 Mouse anti human CD68 antibody, clone KP1 recognises the human CD68 cell surface antigen, a 110kD glycoprotein primarily expressed by macrophages and monocytes. |
---|---|
反应物种 | Hu, Rat, NHuPrm |
应用 | FACS, ICC/IF |
宿主 | Mouse |
克隆 | Monoclonal |
克隆号 | KP1 |
同位型 | IgG1 |
靶点名称 | CD68 |
抗原物种 | Human |
抗原 | Subcellular fraction of Human alveolar macrophages |
偶联标记 | FITC |
別名 | Macrosialin; CD antigen CD68; LAMP4; Gp110; GP110; SCARD1 |
应用建议 |
| ||||||
---|---|---|---|---|---|---|---|
应用说明 | FACS: Membrane permeabilization is required for this application. Use 10 µl of the suggested working dilution to label 10^6 cells in 100 µl. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
形式 | Liquid |
---|---|
纯化 | Purification with Protein G. |
缓冲液 | PBS, 0.09% Sodium azide and 1% BSA |
抗菌剂 | 0.09% Sodium azide |
稳定剂 | 1% BSA |
浓度 | 0.1 mg/ml |
存放说明 | Aliquot and store in the dark at 2-8°C. Keep protected from prolonged exposure to light. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
注意事项 | For laboratory research only, not for drug, diagnostic or other use. |
数据库连接 | |
---|---|
基因名称 | CD68 |
全名 | CD68 molecule |
背景介绍 | CD68 is a 110-kD transmembrane glycoprotein that is highly expressed by human monocytes and tissue macrophages. It is a member of the lysosomal/endosomal-associated membrane glycoprotein (LAMP) family. The protein primarily localizes to lysosomes and endosomes with a smaller fraction circulating to the cell surface. It is a type I integral membrane protein with a heavily glycosylated extracellular domain and binds to tissue- and organ-specific lectins or selectins. The protein is also a member of the scavenger receptor family. Scavenger receptors typically function to clear cellular debris, promote phagocytosis, and mediate the recruitment and activation of macrophages. Alternative splicing results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008] |
生物功能 | CD68 could play a role in phagocytic activities of tissue macrophages, both in intracellular lysosomal metabolism and extracellular cell-cell and cell-pathogen interactions. Binds to tissue- and organ-specific lectins or selectins, allowing homing of macrophage subsets to particular sites. Rapid recirculation of CD68 from endosomes and lysosomes to the plasma membrane may allow macrophages to crawl over selectin-bearing substrates or other cells. [UniProt] |
产品亮点 | Related products: CD68 antibodies; CD68 Duos / Panels; Anti-Mouse IgG secondary antibodies; Related news: New antibody panels and duos for Tumor immune microenvironment Tumor-Infiltrating Lymphocytes (TILs) Exploring Antiviral Immune Response Anti-SerpinB9 therapy, a new strategy for cancer therapy RIP1 activation and pathogenesis of NASH |
研究领域 | Immune System antibody; Activated Macrophage/Microglia Study antibody; Neuroinflammation Study antibody; Active macroglial Marker antibody; M1/M2/TAM Marker antibody; Macrophage Marker antibody; M1 macrophage Marker antibody; Inflammatory Cell Marker antibody |
预测分子量 | 37 kDa |
翻译后修饰 | N- and O-glycosylated. |
ARG23069 anti-CD68 antibody [KP1] (FITC) FACS image
Flow Cytometry: Human peripheral blood granulocytes stained with ARG23069 anti-CD68 antibody [KP1] (FITC). Permeabilisation was with Leucoperm.
ARG23069 anti-CD68 antibody [KP1] (FITC) FACS image
Flow Cytometry: Dot Blot showing FSC/SSC gated Human peripheral blood monocytes dual stained with ARG23069 anti-CD68 antibody [KP1] (FITC) at neat and anti-CD14 (A647) at neat. Isotype control pair in red. Permeabilisation was with Leucoperm.
ARG23069 anti-CD68 antibody [KP1] (FITC) FACS image
Flow Cytometry: Dot Blot showing FSC/SSC gated Human peripheral blood monocytes dual stained with ARG23069 anti-CD68 antibody [KP1] (FITC) at neat and anti-CD111b (A647) at neat. Isotype control pair in red. Permeabilisation was with Leucoperm.